New Study Shows Chromium Picolinate and Biotin Combination Significantly Reduces Fasting Blood Glucose in People with Type 2 Diabetes.Business Editors/Health/Medical Writers BIOWIRE2K American Diabetes Association The American Diabetes Association, or the ADA, is an American health organization providing diabetes research, information and advocacy. Founded in 1940, the American Diabetes Association conducts programs in all 50 states and the District of Columbia, reaching hundreds of 64th Annual Scientific Sessions ORLANDO, Fla.--(BUSINESS WIRE)--June 7, 2004 Results From Diachrome(TM) Clinical Trial Presented at American Diabetes Association Scientific Sessions Nutrition 21, Inc. (Nasdaq:NXXI) Results from a new human clinical trial show that daily nutritional supplementation with a combination of chromium picolinate and biotin biotin: see vitamin; coenzyme. biotin Organic compound, part of the vitamin B complex, essential for growth and well-being in animals and some microorganisms. (marketed as Diachrome) significantly reduced fasting blood glucose levels in patients who had type 2 diabetes type 2 diabetes n. See diabetes mellitus. for at least one year. The results, which evaluated 25 people over 30 days, were presented today at the American Diabetes Association (ADA Ada, city, United States Ada (ā`ə), city (1990 pop. 15,820), seat of Pontotoc co., S central Okla.; inc. 1904. It is a large cattle market and the center of a rich oil and ranch area. ) 64th Annual Scientific Sessions in Orlando. The new randomized ran·dom·ize tr.v. ran·dom·ized, ran·dom·iz·ing, ran·dom·iz·es To make random in arrangement, especially in order to control the variables in an experiment. , double-blind, placebo-controlled trial found significant improvements in blood sugar control in patients who had baseline post-prandial blood glucose (PBG PBG abbr. porphobilinogen ) levels above 200 mg/dL, and HbA1c levels greater than or equal to 7% and added Diachrome to their diabetes treatment regimen: -- Fasting Blood Glucose (FBG) levels significantly decreased by an average of 26.2 mg/dL; the significant drop was observed in over 70% of subjects taking Diachrome, compared with just 27% in the placebo group (p less than 0.01). -- Fructosamine Levels showed a mean decrease in the subjects taking Diachrome of -32.4 uM/L, while placebo group levels increased by +7.73 uM/L. The difference between groups approached significance (p less than 0.07), and therefore warrants further study. The fructosamine test provides a measure of average blood glucose levels over several weeks, offering an additional tool to evaluate ongoing treatment effectiveness. "These results indicate that Diachrome should be considered a valuable adjunct therapy for type 2 diabetes patients whose blood sugar levels are not tightly controlled through oral anti-hyperglycemic medications and/or diet and exercise," states Jeffrey Geohas, MD, principal investigator, medical director, Radiant Research, Inc., Chicago. "Diachrome shows effectiveness in improving two important measures of ongoing blood glucose control." According to Anne Daly, MS, RD, BC-ADM, CDE (1) (Computer Desktop Encyclopedia) What you are reading at this very moment. See About this product. (2) (Common Desktop Environment) A user interface for desktop computing from The Open Group. , leading author and expert in diabetes care and education, "Maintaining tight blood sugar control helps reduce the risk of long-term complications often associated with diabetes, and improves quality of life for patients." Daily adds, "The evidence supports Diachrome as a nutritional therapy that is not only safe and effective, but also affordable and convenient to use." Additional data from the trial were reported on May 6th at an American Heart Association American Heart Association (AHA), n.pr a national voluntary health agency that has the goal of increasing public and medical awareness of cardiovascular diseases and stroke, and thereby reducing the number of associated deaths and disabilities. conference. The study found that Diachrome supplementation also provided significant improvement in coronary risk factors, including total cholesterol levels, LDL LDL - ["LDL: A Logic-Based Data-Language", S. Tsur et al, Proc VLDB 1986, Kyoto Japan, Aug 1986, pp.33-41]. ("bad") cholesterol levels and lipid ratios. "These outcomes indicate that Diachrome can have dramatic short term health benefits that could lead to improved and more affordable patient care," said Gail Montgomery, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Nutrition 21, the company that contracted the study. "Over the coming months, we hope to bring forward a conclusive body of evidence that will encourage the healthcare community to adopt Diachrome as a standard nutrient therapy in diabetes care." There are 18.2 million people in the United States who have diabetes. Complications of poor blood glucose control in people with type 2 diabetes, include heart disease and stroke, blindness, nerve damage, kidney damage and amputation amputation (ăm'pyətā`shən), removal of all or part of a limb or other body part. Although amputation has been practiced for centuries, the development of sophisticated techniques for treatment and prevention of infection has greatly . About Nutrition 21 Nutrition 21 is a nutrition bioscience company, which develops and markets nutritional products, with health benefits substantiated by clinical research. The Company markets Chromax, the leading brand of chromium, and holds 35 patents for nutrition products, 22 for chromium compounds and their uses. For more information, visit www.nutrition21.com or www.diachrome.com or call 1-866-DIACHROME. Nutrition 21 commissioned the study through Radiant Research, Inc. The results were presented as part of an ADA conference session on nutrition and diabetes, by Manley Finch, Associate Director Clinical Research at Nutrition 21, Inc. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion